Not all patients with CLL need therapy. In spite of all modern innovations, the iwCLL even now recommends watchful observation for sufferers with asymptomatic illness.86 This recommendation is predicated on no less than two randomized trials comparing observation to either chlorambucil monotherapy or fludarabine, cyclophosphamide and rituximab (FCR). 26 Conversely, https://englandh319hry7.blogginaway.com/profile